Submitted by: Submitted by marketresearchri
Views: 10
Words: 891
Pages: 4
Category: Other Topics
Date Submitted: 02/23/2016 12:34 AM
B-Cell Non-Hodgkin Lymphoma Industry Share and
Size, Trends and Growth, Analysis and Pipeline
Review, H2 2015
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2015
Summary
Global Markets Direct's, 'B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2015', provides an
overview of the B-Cell Non-Hodgkin Lymphoma's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for B-Cell Non-Hodgkin
Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players involved in the therapeutic development
for B-Cell Non-Hodgkin Lymphoma and special features on late-stage and discontinued projects.
Browse Ongoing Reports http://www.radiantinsights.com/research/b-cell-non-hodgkin-lymphomapipeline-review-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations
and featured press releases from company/university sites and industry-specific third party sources, put
together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic
updation following a stringent set of processes that ensures that all the profiles are updated with the latest
set of information. Additionally, processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent developments are captured on a real time
basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by...